You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

High-risk

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Newly-Diagnosed Prostate Cancer Trial ([18F]PSMA-1007)

Not yet recruiting
  • Prostate Cancer
  • Newly-Diagnosed Prostate Cancer
  • (no location specified)
Nov 3, 2023

Suicide, Mental Health Disorder, Anhedonia Trial (Vira, Treatment as Usual (TAU))

Not yet recruiting
  • Suicide
  • +2 more
  • Vira
  • Treatment as Usual (TAU)
  • (no location specified)
Jun 16, 2023

High-risk Percutaneous Coronary Intervention Trial in New York (The Elevate™ System)

Not yet recruiting
  • High-risk Percutaneous Coronary Intervention
  • The Elevate™ System
  • New York, New York
    New York-Presbyterian Hospital/Columbia University Irving Medica
Feb 3, 2023

Neural Tube Defects, Folic Acid Trial in Istanbul

Completed
  • Neural Tube Defects
  • Folic Acid
    • Istanbul, Sisli, Turkey
      Prof. Dr. Cemil Tascioglu City Hospital
    Nov 13, 2023

    Mpox in HIV Negative High Risk Sexual Health Clinic Attenders

    Not yet recruiting
    • Monkeypox
    • HIV Coinfection
    • No intervention
    • (no location specified)
    Jul 19, 2023

    Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel Trial in Nanjing (Docetaxel injection, Triptorelin Pamoate for

    Active, not recruiting
    • Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
    • Docetaxel injection
    • +2 more
    • Nanjing, Jiangsu, China
      The Affiliated Nanjing Drum Tower Hospital of Nanjing University
    Dec 24, 2022

    High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai

    Recruiting
    • High-risk Stage II Colorectal Cancer
    • +2 more
    • mFOLFIRINOX adjuvant chemotherapy
    • mFOLFOX6/XELOX adjuvant chemotherapy
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 12, 2023

    Neuroblastoma, Ganglioneuroblastoma Trial in Moscow (monoclonal antibodies GD2)

    Recruiting
    • Neuroblastoma
    • Ganglioneuroblastoma
    • monoclonal antibodies GD2
    • Moscow, Russian Federation
      Research Institute of Pediatric Hematology, Oncology and Immunol
    Oct 4, 2023

    Postoperative Gastrointestinal Dysfunction After High Risk

    Recruiting
    • Gastrointestinal Dysfunction
    • +2 more
      • Jakarta Pusat, Jakarta, Indonesia
        Cipto Mangunkusumo Central National Hospital
      May 10, 2023

      Intermediate to High-risk Asymptomatic Sportsmen With Exercise

      Completed
      • Electrocardiography
      • Screening stress test on a bicycle ergometer (usual practise)
      • Saint-Étienne, France
        Centre Hospitalier de Saint-Etienne
      Sep 6, 2023

      High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai (ctDNA

      Recruiting
      • High-risk Stage II Colorectal Cancer
      • +2 more
      • ctDNA methylation dynamic monitoring
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Jun 14, 2023

      Postmenopausal Osteoporosis Trial (Romosozumab)

      Not yet recruiting
      • Postmenopausal Osteoporosis
      • (no location specified)
      Oct 16, 2023

      Patient Satisfaction Trial in Ramat Gan (un-sedated colonoscopies)

      Completed
      • Patient Satisfaction
      • un-sedated colonoscopies
      • Ramat Gan, Israel
        Sheba medical center Tel Hashomer
      Apr 24, 2023

      High-Risk Localized Soft Tissue Sarcoma Trial in Shanghai (Pegylated Liposomal Doxorubicin, Doxorubicin, Anti-PD-1 mAb)

      Recruiting
      • High-Risk Localized Soft Tissue Sarcoma
      • Pegylated Liposomal Doxorubicin
      • +3 more
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Mar 15, 2023

      Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • Residual Disease
      • (no location specified)
      Nov 15, 2023

      Pressure-Volume Loop During High-Risk PCI

      Recruiting
      • Coronary Artery Disease
      • High-risk percutaneous coronary intervention
      • Detroit, Michigan
        Henry Ford Hospital
      Dec 6, 2022

      Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk

      Recruiting
      • Stimulant Abuse
      • Criminal Behavior
      • Decision task
      • Albuquerque, New Mexico
        The Mind Research Network
      Apr 25, 2023

      Prostate Cancer, High Risk Trial in Houston (68Ga-PSMA)

      Active, not recruiting
      Has Results
      • Prostate Cancer
      • High Risk
      • Houston, Texas
        Houston Methodist
      Dec 8, 2022

      Hepatocellular Carcinoma Trial in Tianjin (ultrasonic testing)

      Recruiting
      • Hepatocellular Carcinoma
      • ultrasonic testing
      • Tianjin, Tianjin, China
        王芳
      Nov 20, 2023

      Neuroblastoma Trial (Naxitamab)

      Not yet recruiting
      • Neuroblastoma
      • (no location specified)
      Sep 18, 2023

      Among Patients Undergoing Acute High-risk Abdominal Surgery

      Completed
      • Abdomen, Acute
      • +4 more
      • Troponin I
      • Hillerød, Denmark
        Copenhagen University Hospital - North Zealand
      Aug 15, 2023

      Liver Cirrhosis, Spontaneous Bacterial Peritonitis Trial in New Delhi (20% High Dose Albumin, Standard Medical Treatment, 20%

      Not yet recruiting
      • Liver Cirrhosis
      • Spontaneous Bacterial Peritonitis
      • 20% High Dose Albumin
      • +2 more
      • New Delhi, Delhi, India
        Institute of Liver & Biliary Sciences
      Sep 8, 2023

      Feeding and Eating Disorders Trial (HAPTOS (Handling Adapted to Postnatal age with Tactile-kinaesthetic and Oral sensorimotor

      Not yet recruiting
      • Feeding and Eating Disorders
      • HAPTOS (Handling Adapted to Postnatal age with Tactile-kinaesthetic and Oral sensorimotor Stimulation
      • (no location specified)
      Sep 21, 2023

      Breast Cancer Trial in Shanghai (Regional lymph node radiotherapy, chest/whole breast irradiation)

      Recruiting
      • Breast Cancer
      • Regional lymph node radiotherapy
      • chest/whole breast irradiation
      • Shanghai, Shanghai, China
        Ruijin Hospital, Shanghai jiaotong univestigy school of medicine
      Aug 3, 2023

      Preeclampsia, Perinatal Haemorrhage Trial in Guangzhou (aspirin discontinuation, aspirin continuation)

      Not yet recruiting
      • Preeclampsia
      • Perinatal Haemorrhage
      • aspirin discontinuation
      • aspirin continuation
      • Guangzhou, Guangdong, China
        FANG HE
      Oct 26, 2023